📑Obra de reforma del centro de transfusion, tejidos y celulas de jaen. financiado con fondos react-eu al 100%
Procurement process summary
This process is to purchase Obra de reforma del centro de transfusion, tejidos y celulas de jaen. financiado con fondos react-eu al 100%.
This contract was awarded by 🇪🇸 Servicio Andaluz de Salud for an amount of EUR 376,943 to 1 supplier. It was published on 2022-10-07 through limited
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇪🇸 Servicio Andaluz de Salud Buying unitnot reported Publication date2022-10-07 Contest statusnot reported Descriptionnot reportedAwards
This award was granted to AVANZASI SOCIEDAD LIMITADA by Servicio Andaluz de Salud for an amount of EUR 376,943. The procurement process was conducted through limited for the category of works. This is award number 1.
| Supplier | Amount | Award number |
|---|---|---|
| 🇪🇸 AVANZASI SOCIEDAD LIMITADA | EUR 376,943 | 1 |
Market context and opportunities
The execution of this contract allows the entity Servicio Andaluz de Salud to fulfill its public service objectives efficiently.
The limited purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberES_ocds-70d2nz-1de9bce5-e5d3-4608-9ad3-2117fe6054fe-award-1Publication date2022-10-07Contract datenot reportedAward datenot reportedCategoriesworksPurchase modalitylimitedMethod details9Statusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
